[go: up one dir, main page]

DK0727983T3 - Fremgangsmåde til fremstilling af et clodronat-præparat - Google Patents

Fremgangsmåde til fremstilling af et clodronat-præparat

Info

Publication number
DK0727983T3
DK0727983T3 DK95900155T DK95900155T DK0727983T3 DK 0727983 T3 DK0727983 T3 DK 0727983T3 DK 95900155 T DK95900155 T DK 95900155T DK 95900155 T DK95900155 T DK 95900155T DK 0727983 T3 DK0727983 T3 DK 0727983T3
Authority
DK
Denmark
Prior art keywords
clodronate
pct
preparation
tetrahydrate
disodium
Prior art date
Application number
DK95900155T
Other languages
English (en)
Inventor
Esko Pohjala
Kari Lehmussaari
Heikki Nupponen
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Application granted granted Critical
Publication of DK0727983T3 publication Critical patent/DK0727983T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Ceramic Products (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Seasonings (AREA)
  • Glanulating (AREA)
  • Peptides Or Proteins (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Detergent Compositions (AREA)
  • Glass Compositions (AREA)
DK95900155T 1993-11-12 1994-11-11 Fremgangsmåde til fremstilling af et clodronat-præparat DK0727983T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI935019A FI94926C (fi) 1993-11-12 1993-11-12 Menetelmä klodronaattivalmisteen valmistamiseksi
PCT/FI1994/000509 WO1995013054A1 (en) 1993-11-12 1994-11-11 Process for preparing a clodronate preparation

Publications (1)

Publication Number Publication Date
DK0727983T3 true DK0727983T3 (da) 2001-09-24

Family

ID=8538945

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95900155T DK0727983T3 (da) 1993-11-12 1994-11-11 Fremgangsmåde til fremstilling af et clodronat-præparat

Country Status (25)

Country Link
US (1) US5776499A (da)
EP (1) EP0727983B1 (da)
JP (1) JPH09504800A (da)
KR (1) KR100352155B1 (da)
CN (1) CN1040945C (da)
AT (1) ATE202700T1 (da)
AU (1) AU679586B2 (da)
CA (1) CA2175994A1 (da)
CZ (1) CZ286132B6 (da)
DE (1) DE69427648T2 (da)
DK (1) DK0727983T3 (da)
ES (1) ES2160688T3 (da)
FI (1) FI94926C (da)
GR (1) GR3036470T3 (da)
HU (1) HU220633B1 (da)
IL (1) IL111596A (da)
NO (1) NO312938B1 (da)
NZ (1) NZ275833A (da)
PL (1) PL176658B1 (da)
PT (1) PT727983E (da)
RU (1) RU2141323C1 (da)
SK (1) SK280552B6 (da)
TW (1) TW436297B (da)
WO (1) WO1995013054A1 (da)
ZA (1) ZA948974B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI109088B (fi) * 1997-09-19 2002-05-31 Leiras Oy Tabletti ja menetelmä sen valmistamiseksi
DE19808634A1 (de) * 1998-02-24 1999-08-26 Schering Ag Mantel für eine pharmazeutische Zusammensetzung
AR021347A1 (es) 1999-10-20 2002-07-17 Cipla Ltd Una composicion farmaceutica que contiene acido(s) bisfosfoncio o sal(es) del mismo y un proceso de preparacion de la misma
RO121891B1 (ro) 2001-07-04 2008-07-30 Sindan S.R.L. Compoziţie farmaceutică pentru profilaxia şi tratamentul dereglărilor metabolismului calciului şi procedeu de preparare
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
GB0616794D0 (en) * 2006-08-24 2006-10-04 Arrow Int Ltd Solid dosage form
WO2017111643A1 (ru) * 2015-12-22 2017-06-29 Акционерное Общество "Чепецкий Механический Завод" (Ао Чмз) Способ изготовления прутков из сплавов на основе титана
EP3713581A1 (en) 2017-11-22 2020-09-30 Inbiomotion S.L. Therapeutic treatment of breast cancer based on c-maf
TWI806467B (zh) 2022-03-03 2023-06-21 金兆豐數位科技股份有限公司 金融商品提昇報酬率多維度決策方法
IT202300007269A1 (it) 2023-04-14 2024-10-14 Univ Degli Studi Magna Graecia Di Catanzaro Formulazione farmaceutica composta da Peptide-C associato a un bisfosfonato in forma unica e suo uso nel trattamento dell’osteosarcopenia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2040733T3 (es) * 1986-12-20 1993-11-01 Boehringer Mannheim Gmbh Medicamentos que contienen clodronato y procedimiento para su preparacion.
SE501389C2 (sv) * 1992-04-24 1995-01-30 Leiras Oy Farmaceutiskt preparat och förfarande för dess framställning
ATE128363T1 (de) * 1993-05-15 1995-10-15 Boehringer Mannheim Gmbh Tablette mit verbesserter bioverfügbarkeit enthaltend dichlormethylendiphosphonsäure als wirkstoff.

Also Published As

Publication number Publication date
RU2141323C1 (ru) 1999-11-20
HU9601257D0 (en) 1996-07-29
TW436297B (en) 2001-05-28
DE69427648T2 (de) 2002-04-18
KR100352155B1 (ko) 2002-12-31
AU8108794A (en) 1995-05-29
NZ275833A (en) 1997-10-24
WO1995013054A1 (en) 1995-05-18
CZ132796A3 (en) 1996-10-16
CA2175994A1 (en) 1995-05-18
SK280552B6 (sk) 2000-03-13
NO312938B1 (no) 2002-07-22
HUT75228A (en) 1997-04-28
NO961906D0 (no) 1996-05-10
IL111596A0 (en) 1995-01-24
ZA948974B (en) 1995-11-21
IL111596A (en) 1998-12-06
FI935019A0 (fi) 1993-11-12
US5776499A (en) 1998-07-07
FI94926B (fi) 1995-08-15
DE69427648D1 (de) 2001-08-09
PT727983E (pt) 2001-11-30
KR960705548A (ko) 1996-11-08
FI94926C (fi) 1995-11-27
CN1040945C (zh) 1998-12-02
GR3036470T3 (en) 2001-11-30
EP0727983B1 (en) 2001-07-04
ATE202700T1 (de) 2001-07-15
ES2160688T3 (es) 2001-11-16
CN1134664A (zh) 1996-10-30
FI935019L (fi) 1995-05-13
EP0727983A1 (en) 1996-08-28
AU679586B2 (en) 1997-07-03
SK60696A3 (en) 1997-02-05
HU220633B1 (hu) 2002-03-28
NO961906L (no) 1996-05-23
PL314299A1 (en) 1996-09-02
PL176658B1 (pl) 1999-07-30
CZ286132B6 (cs) 2000-01-12
JPH09504800A (ja) 1997-05-13

Similar Documents

Publication Publication Date Title
DK0675710T3 (da) Fremgangsmåde til fremstilling af farmaceutiske former med styret frigivelse samt de herved opnåede former
CA2265766A1 (en) Rapidly disintegrating pellets
DK74187D0 (da) Praeparat til langsom frigivelse samt fremgangsmaade til fremstilling deraf
MY136231A (en) Slow release compositions
HUT52025A (en) Insecticide compositions containing cyclopropyl-substituted diaryl compounds as active component and process for producing the active components
DK0727983T3 (da) Fremgangsmåde til fremstilling af et clodronat-præparat
HUT47376A (en) Insecticide compositions containing /p-phenoxy-phenoxy/-methyl-heteroaromatic compounds as active components and process for producing the active components
MY113718A (en) Pharmaceutical formulation containing a hydrophobic active substance and an effervescent system, and process for the preparation of the formulation
ATE161423T1 (de) Verwendung von phosphinate zur behandlung der osteoporose
ATE59960T1 (de) Theophyllintabletten mit verzoegerter freigabe.
GR3015719T3 (en) Process for the preparation of a tablet or dragee composition containing a heat-, light- and moisture-sensitive active ingredient having monoclinic crystal structure.
JPS5296729A (en) Mixed vaccin for cyanomycosis
DK0557389T3 (da) Fremgangsmåde til fremstilling af tabletter indeholdende cephalosporansyrederivater ved direkte komprimering
JPS5299207A (en) Remedy for cattle diarrhea
NO154683C (no) Fremgangsmaate for fremstilling av granuler inneholdende urea som hovedkomponent og gjoedningsblandinger av slike granuler.
ES2113408T3 (es) Procedimiento para preparar una composicion detergente granular.
JPS5389367A (en) Substrate crystal for semiconductor epitaxial growth
FR2703262B1 (fr) Mélanges gazeux.
DK260387D0 (da) Soenderdelingsapparat til tilvejebringelse af pastaagtige masser, isaer poelsemasse
HUT52762A (en) Herbicide compositions containing substituted sulfonyl-urea derivatives as active components and process for producing the active components
JPS53103441A (en) Preparation of optical active phenylglycines
RU94018502A (ru) Способ получения гербицидных гранулированных продуктов
JPS5375193A (en) Screening method for slag
JPS53122679A (en) Process for preparing forming tablets
UA6826A (uk) Кристалічний фосфат акваамінкобальту /п/ та спосіб його одержання